norfloxacin has been researched along with kanamycin a in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (8.89) | 18.7374 |
1990's | 5 (11.11) | 18.2507 |
2000's | 14 (31.11) | 29.6817 |
2010's | 19 (42.22) | 24.3611 |
2020's | 3 (6.67) | 2.80 |
Authors | Studies |
---|---|
Courvalin, P; Galimand, M; Périchon, B | 1 |
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
Wang, X; Zhao, X | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Hashida, Y; Konaka, R; Kourai, H; Maseda, H; Shirai, A | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Blango, MG; Mulvey, MA | 1 |
Mima, T; Schweizer, HP | 1 |
Bohnert, JA; Karamian, B; Nikaido, H | 1 |
Dhamdhere, G; Krishnamoorthy, G; Zgurskaya, HI | 1 |
Deng, RC; Dong, JJ; Gao, XM; Li, ST; Lin, WQ; Lu, CL; Peng, ZY; Wang, XD; Xiao, ZP; Zhu, HL | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chaudhary, AS; Cui, J; Damera, K; Hsieh, YH; Jin, J; Tai, PC; Wang, B; Yang, H; Zhang, H | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gruber, JD; Pachaiyappan, B; Schmidt, MG; Wang, B; Woster, PM; Zhang, YM | 1 |
Bukhari, SNA; Mallesha, N; Manukumar, HM; Qin, HL; Rakesh, KP; Vivek, HK; Wang, SM; Zha, GF | 1 |
Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ | 1 |
Zhang, B | 1 |
Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
Ba, Y; Hou, X; Wang, S; Xu, Z; Yang, H; Zhang, J | 1 |
Chen, Y; Fang, S; Li, H; Lin, S; Liu, J; Liu, S; Zhong, R | 1 |
Bogaerts, J; Dekegel, M; Piot, P; Van Dyck, E; Vandepitte, J; Vanhoof, R | 1 |
Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 1 |
Husson, M; Klastersky, J; Lauzon, D; Lieppe, S; Lopez, AP; Van der Auwera, P | 1 |
de Moor, G; Lacroix, G; Mambour, A; Rossion, N; Schuyteneer, F; van der Auwera, P | 1 |
Maruyama, S; Sakata, H | 1 |
Gwanzura, L; Katzenstein, DA; Latif, AS; Marowa, E; Mason, PR; Ray, S | 1 |
Harada, H; Kita, E; Kurioka, T; Yunou, Y | 1 |
Fujii, J; Taniguchi, H; Yoshida, S; Yoshimura, K | 1 |
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
Bittner, A; Lerner, D; Liu, X; Miller, N; Morrow, BJ; Shaw, KJ; Wan, J | 1 |
Tabata, M; Takata, T; Tsuruoka, T; Watabe, H | 1 |
Ishitobi, J; Kamiya, A; Oie, S; Sawa, A; Tomita, M | 1 |
Chiung, YM; Han, JM; Lai, HL; Lin, WP; Liu, YL; Liu, YT; Shiau, CY; Yang, CM | 1 |
Wright, GD | 1 |
Collins, JJ; Dwyer, DJ; Hayete, B; Kohanski, MA; Lawrence, CA | 1 |
Collins, JJ; Devadoss, B; Foti, JJ; Walker, GC; Winkler, JA | 1 |
Imlay, JA; Liu, Y | 1 |
Belenky, P; Cohen, NR; Collins, JJ; Ferrante, T; Jain, S; Korry, BJ; Lobritz, MA; Porter, CB; Schwarz, EG; Walker, GC; Ye, JD | 1 |
Cho, DH; Heo, P; Jin, YS; Jung, SC; Kim, JS; Kim, PJ; Kweon, DH; Lee, CH; Lee, DH; Lee, S; Lee, SC; Oh, EJ; Park, M; Shin, D; Sung, J | 1 |
Dong, L; Gao, F; Liu, Y; Sun, X; Wu, C; Yu, L; Zhang, G; Zhang, J | 1 |
Adhikary, A; Biswal, S; Chatterjee, D; Ghosh, AS | 1 |
5 review(s) available for norfloxacin and kanamycin a
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluoroquinolone-isatin hybrids and their biological activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship | 2019 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
Topics: Anti-Bacterial Agents; Bacterial Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles | 2019 |
40 other study(ies) available for norfloxacin and kanamycin a
Article | Year |
---|---|
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Contribution of oxidative damage to antimicrobial lethality.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Bacterial Proteins; Catalase; Escherichia coli; Escherichia coli Proteins; Hydroxyl Radical; Microbial Sensitivity Tests; Norfloxacin; Oxidative Stress; Superoxide Dismutase; Thiourea | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cetylpyridinium; Disinfectants; Drug Resistance, Multiple, Bacterial; Membrane Proteins; Mutation; Norfloxacin; Quaternary Ammonium Compounds; Serratia marcescens | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antioxidants; Erythromycin; Escherichia coli; Glutathione; Kanamycin; Microbial Sensitivity Tests; Novobiocin; Spermidine | 2010 |
3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
Topics: Anti-Infective Agents; Binding Sites; Catalytic Domain; Enzyme Inhibitors; Fungi; Furans; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Docking Simulation; Staphylococcus aureus; Structure-Activity Relationship; Thermodynamics; Tyrosine-tRNA Ligase | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus.
Topics: Adenosine Triphosphatases; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Binding Sites; Drug Evaluation, Preclinical; Enzyme Inhibitors; Kinetics; Light; Membrane Transport Proteins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxidation-Reduction; Protein Structure, Tertiary; Rose Bengal; SEC Translocation Channels; SecA Proteins; Staphylococcus aureus | 2015 |
Antibacterial Diamines Targeting Bacterial Membranes.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Cell Membrane; Cell Membrane Permeability; Chemistry Techniques, Synthetic; Diamines; Drug Evaluation, Preclinical; Drug Interactions; Escherichia coli; HEK293 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 2016 |
Discovery of novel arylethenesulfonyl fluorides as potential candidates against methicillin-resistant of Staphylococcus aureus (MRSA) for overcoming multidrug resistance of bacterial infections.
Topics: Bacterial Infections; Biofilms; Drug Resistance, Multiple; Electron Transport Chain Complex Proteins; Fluorides; Methicillin-Resistant Staphylococcus aureus; Molecular Docking Simulation; Oxidation-Reduction; Staphylococcal Infections; Sulfinic Acids; Sulfones | 2019 |
Synthesis and biological evaluation of indole-based peptidomimetics as antibacterial agents against Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Molecular Structure; Peptidomimetics; Structure-Activity Relationship | 2021 |
In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda.
Topics: Anti-Bacterial Agents; Kanamycin; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillin G; Penicillin Resistance; Penicillinase; R Factors; Rwanda; Spectinomycin; Tetracycline; Thiamphenicol | 1986 |
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1986 |
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Topics: Amikacin; Ampicillin; Cephalothin; Drug Combinations; Drug Interactions; Enterobacteriaceae; Escherichia coli; Female; Humans; Infusions, Parenteral; Kanamycin; Klebsiella pneumoniae; Male; Norfloxacin; Oxacillin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1986 |
In vitro activity of enoxacin compared with norfloxacin and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Calcium; Drug Interactions; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Kanamycin; Magnesium; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1985 |
[Result of antibiotic therapy for children with Escherichia coli O26:H11 infection].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Disease Outbreaks; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Japan; Kanamycin; Norfloxacin; Retrospective Studies | 1998 |
Antimicrobial resistance in gonococci isolated from patients and from commercial sex workers in Harare, Zimbabwe.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactam Resistance; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Gonorrhea; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillinase; Sex Work; Zimbabwe | 1997 |
Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Toxins; Brain Chemistry; Disease Models, Animal; Disease Progression; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Kanamycin; Mice; Mice, Inbred C57BL; Norfloxacin; Protein-Energy Malnutrition; Reference Values; Sensitivity and Specificity; Shiga Toxins; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Colony Count, Microbial; Drug Synergism; Enterotoxins; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Injections, Intraperitoneal; Kanamycin; Male; Mice; Mice, Inbred ICR; Minocycline; Mitomycin; Norfloxacin; Shiga Toxin 2 | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents.
Topics: Ampicillin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Gene Expression; Gene Expression Profiling; Kanamycin; Microbial Sensitivity Tests; Norfloxacin; Oligonucleotide Array Sequence Analysis; Rifampin; Transcription, Genetic | 2003 |
[Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins].
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriolysis; Cell Wall; Chloramphenicol; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Kanamycin; Norfloxacin; Shiga Toxins | 2003 |
In vitro bactericidal activity of antimicrobial agents against enterohaemorrhagic Escherichia coli.
Topics: Anti-Bacterial Agents; Cefoperazone; Electrophoresis, Gel, Pulsed-Field; Escherichia coli O157; Fosfomycin; Kanamycin; Microbial Sensitivity Tests; Norfloxacin | 2004 |
Effect of melanin produced by a recombinant Escherichia coli on antibacterial activity of antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Kanamycin; Melanins; Microbial Sensitivity Tests; Molecular Structure; Norfloxacin; Plasmids; Polymyxin B; Recombinant Proteins; Spectrum Analysis; Tetracycline | 2005 |
On the road to bacterial cell death.
Topics: Ampicillin; Anti-Bacterial Agents; Carbon-Sulfur Lyases; Cell Death; Citric Acid Cycle; DNA Damage; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Ferrous Compounds; Gene Expression Regulation, Bacterial; Hydrogen Peroxide; Hydroxyl Radical; Kanamycin; Membrane Proteins; Microbial Viability; Mutation; NAD; Norfloxacin; Oxidative Stress; Rec A Recombinases; Staphylococcus aureus; Time Factors | 2007 |
A common mechanism of cellular death induced by bactericidal antibiotics.
Topics: 2,2'-Dipyridyl; Ampicillin; Anti-Bacterial Agents; Carbon-Sulfur Lyases; Cell Death; Citric Acid Cycle; Colony Count, Microbial; DNA Damage; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Ferrous Compounds; Free Radical Scavengers; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Hydrogen Peroxide; Hydroxyl Radical; Hydroxyurea; Iron Chelating Agents; Kanamycin; Membrane Proteins; Microbial Viability; Mutation; NAD; Norfloxacin; Oxidative Stress; Rec A Recombinases; Staphylococcus aureus; Time Factors | 2007 |
Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Deoxyguanine Nucleotides; DNA Breaks, Double-Stranded; DNA Glycosylases; DNA Polymerase beta; DNA Polymerase I; DNA Polymerase II; DNA-Directed DNA Polymerase; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Guanine; Guanine Nucleotides; Hydroxyl Radical; Kanamycin; Microbial Viability; Models, Biological; Norfloxacin; Oxidation-Reduction; Pyrophosphatases; RNA, Bacterial | 2012 |
Cell death from antibiotics without the involvement of reactive oxygen species.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; DNA Repair; DNA Replication; Drug Resistance, Bacterial; Escherichia coli; Hydrogen Peroxide; Iron; Kanamycin; Norfloxacin; Oxidative Stress; Protein Biosynthesis; Reactive Oxygen Species | 2013 |
Bactericidal Antibiotics Induce Toxic Metabolic Perturbations that Lead to Cellular Damage.
Topics: Ampicillin; Anti-Bacterial Agents; DNA Breaks, Double-Stranded; Escherichia coli; Kanamycin; Norfloxacin; Oxidative Stress | 2015 |
Fumarate-Mediated Persistence of Escherichia coli against Antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Citric Acid Cycle; Drug Resistance, Multiple, Bacterial; Electron Transport; Escherichia coli; Fumarates; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Gene Library; Kanamycin; Microbial Sensitivity Tests; Norfloxacin; Operon; Succinate Dehydrogenase | 2016 |
Isolation and characterisation of Pulsatilla Radix-utilising bacteria Pediococcus pentosaceus PR-1 from human faeces.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antioxidants; Bile Acids and Salts; Feces; Humans; Kanamycin; Norfloxacin; Pediococcus; Pediococcus pentosaceus; Probiotics; Pulsatilla; Streptomycin; Vancomycin | 2022 |
A NiCoT family metal transporter of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cobalt; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Ethambutol; Gentamicins; Isoleucine; Isoniazid; Kanamycin; Leucine; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Neomycin; Nickel; Norfloxacin; Ofloxacin | 2022 |